NASDAQ
Autolus Therapeutics plc (AUTL) has a free cash flow growth of 25.34% as of Friday, May 29, 2026. This represents a 243.83% increase compared to its 12-month average of -17.62%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.